Literature DB >> 15557916

Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion.

Giorgio Ghilardi1, Maria Luisa Biondi, Lodovica Battaglioli, Antonella Zambon, Emma Guagnellini, Roberto Scorza.   

Abstract

OBJECTIVE: Inflammation is involved in the pathogenesis of atherosclerosis and abdominal aortic aneurysm (AAA), and chemokines are mediators of the inflammatory process. The homozygous Delta 32 deletion mutation of the gene of the chemokine receptor CCR5 is a cause of its lack in inflammatory cells. The purpose of this study was to investigate the relationship between CCR5 Delta 32 deletion mutation and AAA, peripheral arterial occlusive disease (PAOD), and carotid stenosis.
METHODS: The CCR5 Delta 32 polymorphism was genotyped in 380 subjects: 70 patients operated on to treat AAA (21 ruptured AAAs, 49 elective repair), 76 patients with PAOD, 62 patients with carotid stenosis, and 172 age-matched and sex-matched healthy control subjects. Risk factors for AAA were considered. Each patient was assessed according to a diagnostic procedure tailored to symptoms at presentation.
RESULTS: In patients with AAA the Delta allelic variation was significantly different compared with control subjects (P = .002; odds ratio [OR], 2.7; 95% confidence interval [CI], 1.41-5.15). The increased presence of this allele differentiates AAA from both PAOD (P = .017; OR, 2.77; 95% CI, 1.17-6.52) and carotid stenosis (P = .01; OR, 3.47; 95% CI, 1.31-9.11). The presence in the genotype of patients with AAA of at least 1 Delta 32 allele is more frequent in ruptured AAAs than in electively repaired AAAs (genotype: OR, 4.04; 95% CI, 1.34-12.1; P = .011; allelic frequency: OR, 2.75; 95% CI, 1.07-7.07; P = .035). Among the patients, multiple regression analysis showed that the Delta 32 allele is an independent risk factor for AAA vs PAOD (OR, 3.13; 95% CI, 1.33-7.33; P = .012) and for ruptured AAAs vs electively repaired AAAs (OR, 3.52; 95% CI, 1.01-11.80; P = .045).
CONCLUSIONS: CCR5 Delta 32 deletion mutation is significantly more frequent in patients with AAA than in control subjects and in both patients with PAOD and carotid stenosis, and could be a factor that differentiates AAA from PAOD, and ruptured AAAs from AAAs that can be electively repaired. CLINICAL RELEVANCE: The major threat of abdominal aortic aneurysm (AAA) is rupture, accounting for extremely high mortality. This occurrence has been correlated to aneurysm size, but it is a common observation that small AAAs can rupture and large AAAs can remain stable for many years. This study was carried out in an attempt to search for genetic markers of aneurysm rupture. Some single nucleotide polymorphisms are implicated in acceleration of transcription for enzymes involved in the inflammatory process and in extracellular matrix remodeling. An association between single nucleotide polymorphisms and aneurysm rupture could enable better selection for surgical indications in patients with small AAs and in patients at poor risk with large AAAs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557916     DOI: 10.1016/j.jvs.2004.08.014

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

Review 1.  Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead.

Authors:  Nathan Belkin; Scott M Damrauer
Journal:  Curr Cardiol Rep       Date:  2017-11-01       Impact factor: 2.931

Review 2.  Genes and abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2010-12-13       Impact factor: 1.466

Review 3.  Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology.

Authors:  Joshua W Knowles; Themistocles L Assimes; Jun Li; Thomas Quertermous; John P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-26       Impact factor: 8.311

4.  Prevention of CaCl2-induced aortic inflammation and subsequent aneurysm formation by the CCL3-CCR5 axis.

Authors:  Yuko Ishida; Yumi Kuninaka; Mizuho Nosaka; Akihiko Kimura; Akira Taruya; Machi Furuta; Naofumi Mukaida; Toshikazu Kondo
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

Review 5.  Cytokines in Abdominal Aortic Aneurysm: Master Regulators With Clinical Application.

Authors:  Olesya A Puchenkova; Vladislav O Soldatov; Andrei E Belykh; OlgaYu Bushueva; Gennadii A Piavchenko; Artem A Venediktov; Nikolay K Shakhpazyan; Alexey V Deykin; Mikhail V Korokin; Mikhail V Pokrovskiy
Journal:  Biomark Insights       Date:  2022-04-25

6.  Systematic Review of Circulating, Biomechanical, and Genetic Markers for the Prediction of Abdominal Aortic Aneurysm Growth and Rupture.

Authors:  Menno E Groeneveld; Jorn P Meekel; Sidney M Rubinstein; Lisanne R Merkestein; Geert Jan Tangelder; Willem Wisselink; Maarten Truijers; Kak Khee Yeung
Journal:  J Am Heart Assoc       Date:  2018-06-30       Impact factor: 5.501

7.  Weighted Gene Co-Expression Network Analysis Reveals Key Genes and Potential Drugs in Abdominal Aortic Aneurysm.

Authors:  Ke-Jia Kan; Feng Guo; Lei Zhu; Prama Pallavi; Martin Sigl; Michael Keese
Journal:  Biomedicines       Date:  2021-05-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.